Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway

Original language	American English
State	Published - 2016
Event	Meeting on Personalized Patient Care in Lung Cancer - Herzliya, Israel Duration: 23 Jun 2016 → 23 Jun 2016

Conference

Conference	Meeting on Personalized Patient Care in Lung Cancer
Country/Territory	Israel
City	Herzliya
Period	23/06/16 → 23/06/16

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Activities

• 1 Organizing a conference, workshop, ...

Activities per year

• Meeting on Personalized Patient Care in Lung Cancer

  Cohen, C. (Participation - Conference participant)

  23 Jun 2016

  Activity: Participating in or organizing an event › Organizing a conference, workshop, ...

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Cohen, C. (2016). Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway. Paper presented at Meeting on Personalized Patient Care in Lung Cancer, Herzliya, Israel.

Cohen, C. / Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway. Paper presented at Meeting on Personalized Patient Care in Lung Cancer, Herzliya, Israel.

@conference{47194e70f7774008a32696f1d9f0d223,

title = "Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway",

author = "C. Cohen",

year = "2016",

language = "American English",

note = "Meeting on Personalized Patient Care in Lung Cancer ; Conference date: 23-06-2016 Through 23-06-2016",

}

Cohen, C 2016, 'Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway', Paper presented at Meeting on Personalized Patient Care in Lung Cancer, Herzliya, Israel, 23/06/16 - 23/06/16.

Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway. / Cohen, C.
2016. Paper presented at Meeting on Personalized Patient Care in Lung Cancer, Herzliya, Israel.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway

AU - Cohen, C.

PY - 2016

Y1 - 2016

M3 - Paper

T2 - Meeting on Personalized Patient Care in Lung Cancer

Y2 - 23 June 2016 through 23 June 2016

ER -

Cohen C. Molecular Biology of Immune Checkpoint Blockade in Cancer Therapy – Influencing the PD1/PDL1 pathway. 2016. Paper presented at Meeting on Personalized Patient Care in Lung Cancer, Herzliya, Israel.